US Women's Health Market Analysis

US Women’s Health Market Executive Summary

The US Women’s Health Market is projected to grow from $16.775 Bn in 2022 to $20.922 Mn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 - 2030.

In 2020, US national health expenditure was seen to rise high up to 19.7% of its Gross Domestic Product (GDP) from 17.6% in 2019. According to World Health Organization (WHO) Global Health Expenditure database, US healthcare expenditure per capita raised to $10,921.01 as compared to $ 10,515.32 in 2018. Healthcare spending in the US has been growing at a faster rate than the overall economy for many years.

In recent years, the US has contributed close to half of the global total in pharmaceutical sales revenues. In 2021, five of the top ten pharmaceutical businesses worldwide were American. Pfizer has surpassed all other American companies in terms of prescription medicine sales worldwide, thanks largely to the success of its COVID-19 vaccine Comirnaty. Another American business that has made a significant impact abroad is AbbVie, whose pharmaceutical operations generated a record 55 billion dollars in revenue in 2021, mostly due to the success of its enduring best-seller Humira.

The Women's Health market in the United States is a large and rapidly growing market, driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The market is expected to reach a value of over $50 billion by 2026, growing at a CAGR of around 5% during the forecast period from 2021 to 2026.

The US women's health market is segmented into various categories such as contraceptives, infertility treatment, menopause, osteoporosis, and cancer. The contraceptive segment is the largest segment, followed by the menopause and infertility treatment segment.

The market is driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The use of contraceptives, for example, has been increasing in recent years, as more women are becoming aware of the importance of family planning and the availability of new and innovative contraceptive products.

The market is also facing some challenges such as the high cost of drugs and treatments, the lack of access to healthcare for some women, and the lack of government investment in the women's health sector. These challenges can impede market growth and access to treatment.

In summary, the US women's health market is a large and rapidly growing market, driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The market is expected to continue to grow in the coming years, but there are some challenges to overcome as well.

​

Market Dynamics

Market Growth Drivers

The key drivers of the US Women's Health market include:

1. Increasing awareness and understanding of women's health issues: As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing.
2. Aging population: The aging of the population is a significant driver of the women's health market, as women are more likely to experience health issues as they get older.
3. Government support and initiatives: Government support and initiatives, such as the Affordable Care Act (ACA) and the Women's Health Amendment, have increased access to healthcare for women and have led to increased funding for women's health research and education.
4. Technological advancements: Advances in technology have led to the development of new and innovative products and treatments for women's health, such as hormonal contraceptives and osteoporosis drugs, which are driving the growth of the market.
5. Increase in disposable income: The increase in disposable income of people across the US has led to an increase in the adoption of expensive treatments and drugs for women's health.
6. Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases such as osteoporosis and cancer is also driving the growth of the women's health market.

Overall, these factors are driving the growth of the US women's health market and are expected to continue to do so in the coming years.

Competitive Landscape

Key Players

Some key players in the US Women's Health market include:

• Pfizer
• Merck
• AbbVie
• Allergan
• GlaxoSmithKline
• Lilly
• Novo Nordisk
• Roche
• Sanofi
• Teva
• Mylan
• Actavis

These companies are involved in the development, manufacturing, and distribution of various women's health products such as contraceptives, infertility treatment, menopause, osteoporosis, and cancer treatments. They also invest heavily in research and development to bring new and innovative products to the market. They also have a wide distribution network which enables them to reach most of the population, making their products widely available.

Healthcare Policies and Regulatory Landscape

In the United States, the Food and Drug Administration (FDA) is responsible for regulating and approving the use of drugs and medical devices for the treatment of women's health issues. The FDA reviews and approves new drugs and medical devices for safety and efficacy before they can be marketed and sold in the US.

The US healthcare system is a complex mix of public and private insurance, with the largest public program being Medicaid and the largest private program being employer-sponsored insurance. The government also runs Medicare, which is a federal program that provides health insurance coverage to people over 65 and some people with disabilities.

The Affordable Care Act (ACA) has had a significant impact on women's health in the US. The ACA requires insurance plans to cover certain women's health services, including contraception, without cost-sharing. This has increased access to contraceptives for many women and has helped to reduce the rate of unintended pregnancies in the US.

The US also has several laws and regulations in place to protect women's rights and access to healthcare. For example, the Pregnancy Discrimination Act prohibits discrimination on the basis of pregnancy, childbirth, or related medical conditions. Additionally, the Women's Health Amendment to the Affordable Care Act requires that certain preventative services, such as mammograms and cervical cancer screenings, be covered without cost-sharing.

The FDA also has regulations in place to ensure the safety and efficacy of drugs and medical devices used in the treatment of women's health issues. The FDA has several programs in place to review and approve new drugs and medical devices for safety and efficacy and to monitor the safety of drugs and medical devices after they have been approved and are on the market.

Overall, the US has a complex healthcare system, with a mix of public and private insurance, and a range of laws and regulations in place to protect women's rights and access to healthcare. The Affordable Care Act has had a significant impact on women's health by increasing access to contraceptives, and other laws and regulations have helped to protect women's rights and access to healthcare. The FDA also plays a significant role in ensuring the safety and efficacy of drugs and medical devices used in the treatment of women's health issues.